Caxton Associates (New York)’s Biogen BIIB Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q1 | – | Sell |
-45,000
| Closed | -$11.6M | – | 464 |
|
|
2023
Q4 | $11.6M | Buy |
+45,000
| New | +$11.6M | 0.6% | 43 |
|
|
2022
Q1 | – | Sell |
-2,332
| Closed | -$559K | – | 493 |
|
|
2021
Q4 | $559K | Buy |
+2,332
| New | +$559K | 0.06% | 231 |
|
|
2020
Q4 | – | Sell |
-1,110
| Closed | -$315K | – | 132 |
|
|
2020
Q3 | $315K | Sell |
1,110
-222
| -17% | -$63K | 0.03% | 179 |
|
|
2020
Q2 | $356K | Sell |
1,332
-3,943
| -75% | -$1.05M | 0.03% | 190 |
|
|
2020
Q1 | $1.67M | Buy |
+5,275
| New | +$1.67M | 0.31% | 23 |
|
|
2018
Q4 | – | Sell |
-5,867
| Closed | -$2.07M | – | 278 |
|
|
2018
Q3 | $2.07M | Buy |
+5,867
| New | +$2.07M | 0.14% | 82 |
|
|
2018
Q2 | – | Sell |
-2,671
| Closed | -$731K | – | 333 |
|
|
2018
Q1 | $731K | Sell |
2,671
-195
| -7% | -$53.4K | 0.04% | 179 |
|
|
2017
Q4 | $913K | Buy |
+2,866
| New | +$913K | 0.04% | 174 |
|
|
2017
Q3 | – | Sell |
-1,500
| Closed | -$407K | – | 446 |
|
|
2017
Q2 | $407K | Buy |
1,500
+300
| +25% | +$81.4K | 0.02% | 347 |
|
|
2017
Q1 | $328K | Buy |
+1,200
| New | +$328K | ﹤0.01% | 282 |
|
|
2014
Q2 | – | Sell |
-10,000
| Closed | -$3.06M | – | 158 |
|
|
2014
Q1 | $3.06M | Buy |
+10,000
| New | +$3.06M | 0.19% | 70 |
|